GO:0034594 phosphatidylinositol trisphosphate phosphatase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0034594 describes the enzymatic activity that removes a phosphate from phosphatidylinositol trisphosphate (PIP3), converting it to phosphatidylinositol bisphosphate (PIP2).
• This activity is critical for terminating PI3K signaling and is carried out by several distinct phosphatases, including PTEN, SHIP1, SHIP2, SKIP, and VSP [1,2,4,5,6].
• Loss of phosphatidylinositol trisphosphate phosphatase activity leads to accumulation of PIP3, hyperactivation of AKT, and is implicated in cancer, autism, insulin resistance, and adrenal lipoma formation [2,6,7].
• The catalytic mechanism involves a conserved CX5R motif and is regulated by anionic lipids, ER stress, and protein-protein interactions [4,6,8].
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) are essential to dissect the specific roles of each phosphatase in health and disease [2,6,7].
• Studying this activity requires a combination of lipidomics, phosphoproteomics, live-cell imaging, and functional assays such as AKT phosphorylation [2,4,7].
Description
Phosphatidylinositol trisphosphate (PIP3) is a key lipid second messenger that drives cell survival, proliferation, and migration. The enzyme activity that removes the 3-phosphate from PIP3 to generate phosphatidylinositol bisphosphate (PIP2) is defined by the Gene Ontology term GO:0034594, phosphatidylinositol trisphosphate phosphatase activity. This activity is essential for attenuating PI3K signaling and preventing uncontrolled cellular growth. Researchers study this activity to understand how cells maintain lipid homeostasis and how its dysregulation contributes to diseases such as cancer, autism, and metabolic disorders [1,2,6]. The major enzymes exhibiting this activity include PTEN, SHIP1, SHIP2, SKIP, and VSP, each with distinct substrate specificities and regulatory mechanisms [1,2,4,5,6]. Understanding the molecular details of this activity is crucial for developing targeted therapies that modulate PIP3 levels.
phosphatidylinositol trisphosphate phosphatase activity At A Glance
| GO ID | GO:0034594 |
|---|---|
| GO term | phosphatidylinositol trisphosphate phosphatase activity |
| Ontology | molecular_function |
| Synonym | none |
| Major function | Catalysis of the dephosphorylation of phosphatidylinositol trisphosphate to phosphatidylinositol bisphosphate |
| Reaction | phosphatidylinositol trisphosphate + H2O = phosphatidylinositol bisphosphate + phosphate |
| Major enzymes | PTEN, SHIP1, SHIP2, SKIP, VSP |
| Subcellular location | cytosol, plasma membrane, endoplasmic reticulum |
| Disease relevance | cancer, autism, insulin resistance, adrenal lipoma |
What Is GO:0034594?
Phosphatidylinositol trisphosphate phosphatase activity (GO:0034594) is defined as the catalysis of the reaction: phosphatidylinositol trisphosphate + H2O = phosphatidylinositol bisphosphate + phosphate. In other words, it is the enzymatic removal of a phosphate group from PIP3, typically at the 3-position or 5-position, yielding PIP2 and inorganic phosphate.
Why Is phosphatidylinositol trisphosphate phosphatase activity Important in Cell Biology?
Phosphatidylinositol trisphosphate phosphatase activity is a central negative regulator of the PI3K/AKT signaling pathway, which controls cell growth, survival, and metabolism. Dysregulation of this activity leads to excessive PIP3 accumulation and hyperactive AKT, a hallmark of many cancers and metabolic disorders [1,2,6]. Moreover, mutations in genes encoding these phosphatases, such as PTEN, are linked to tumor syndromes and autism spectrum disorders. Therefore, understanding this activity is vital for developing precision therapies and diagnostic biomarkers.
• Terminates PI3K signaling by dephosphorylating PIP3, thereby preventing sustained AKT activation.
• Mutations in PTEN, a major PIP3 phosphatase, cause Cowden syndrome and are frequent in sporadic cancers.
• SHIP2 regulates insulin sensitivity and its inhibition improves glucose uptake in skeletal muscle.
• SKIP links endoplasmic reticulum stress to insulin resistance in skeletal muscle.
• VSP is a voltage-sensing phosphatase that can dephosphorylate PI(3,4)P2, expanding the repertoire of 3-phosphatases.
• Loss of this activity contributes to adrenal lipoma formation via PI(3,4,5)P3/AKT-dependent transdifferentiation.
• Anionic lipids such as phosphatidylserine modulate SHIP2 activity, highlighting membrane-dependent regulation.
• The activity is essential for proper neuronal development and synaptic plasticity, with implications for autism.
• Targeting these phosphatases is a promising strategy for cancer therapy and metabolic disease intervention.
• Understanding substrate specificity (PIP3 vs PI(3,4)P2) is key to designing selective inhibitors [5,8].
Molecular Mechanism of phosphatidylinositol trisphosphate phosphatase activity
Substrate recognition and binding
In simple terms: The enzyme grabs PIP3 from the membrane.
Phosphatidylinositol trisphosphate phosphatases contain a catalytic domain that binds the inositol headgroup of PIP3. For PTEN, the C2 domain facilitates membrane recruitment by interacting with phosphatidylserine and other anionic lipids. SHIP2 also requires anionic lipids for optimal activity, as shown by in vitro studies. The substrate specificity is determined by the active site architecture, which accommodates the 3,4,5-trisphosphate moiety.
Catalytic dephosphorylation
In simple terms: The enzyme cuts off a phosphate group from PIP3.
The catalytic mechanism involves a conserved CX5R motif that forms a phosphate-binding loop. In PTEN, the cysteine acts as a nucleophile, attacking the 3-phosphate of PIP3, resulting in the formation of a phosphoenzyme intermediate and release of PIP2. SHIP1 and SHIP2 remove the 5-phosphate, generating PI(3,4)P2 [1,4]. VSP can act as a 3-phosphatase toward PI(3,4)P2, indicating broader substrate tolerance.
Product release and membrane dissociation
In simple terms: The enzyme lets go of the product and leaves the membrane.
After dephosphorylation, the product PIP2 is released into the membrane, where it can serve as a substrate for other enzymes or be further metabolized. The enzyme may undergo conformational changes that reduce its affinity for the membrane, allowing it to cycle to the cytosol. For SHIP2, product release is influenced by the lipid environment.
Regulation by protein-protein interactions
In simple terms: Other proteins can turn the enzyme on or off.
SHIP2 activity is regulated by interactions with adaptor proteins such as Shc and Grb2, which recruit it to activated receptor tyrosine kinases. SKIP is regulated by ER stress, which induces its expression and activity in skeletal muscle. PTEN is regulated by phosphorylation of its C-terminal tail, which controls its membrane recruitment and stability.
Cofactors and post-translational modifications
In simple terms: Small molecules and chemical tags can change how well the enzyme works.
Phosphatidylinositol trisphosphate phosphatases require magnesium ions for catalysis. PTEN activity is modulated by oxidation of its active-site cysteine, which inactivates it. SHIP2 is subject to phosphorylation by Src and other kinases, affecting its localization and activity. These modifications provide additional layers of regulation in response to cellular signals.
Key Genes Involved in GO:0034594 phosphatidylinositol trisphosphate phosphatase activity
The following genes encode enzymes with phosphatidylinositol trisphosphate phosphatase activity or directly regulate this activity.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PTEN | 3-phosphatase that converts PIP3 to PI(4,5)P2 | Tumor suppressor, mutated in cancers and autism |
| INPP5D (SHIP1) | 5-phosphatase that converts PIP3 to PI(3,4)P2 | Regulates immune cell signaling, target in leukemia |
| INPPL1 (SHIP2) | 5-phosphatase that converts PIP3 to PI(3,4)P2 | Insulin resistance, diabetes, and cancer [4,8] |
| SKIP (INPP5K) | 5-phosphatase that dephosphorylates PIP3 | ER stress-induced insulin resistance in skeletal muscle |
| VSP (TPTE2) | Voltage-sensing 3-phosphatase toward PI(3,4)P2 | Neuronal signaling, substrate specificity studies |
| PIK3CA | Kinase that generates PIP3 | Oncogene, counteracts phosphatase activity |
| PIK3R1 | Regulatory subunit of PI3K | Modulates PIP3 production |
| AKT1 | Serine/threonine kinase activated by PIP3 | Downstream effector of PIP3 signaling |
| AKT2 | Serine/threonine kinase activated by PIP3 | Metabolic regulation, insulin signaling |
| AKT3 | Serine/threonine kinase activated by PIP3 | Brain development, cancer |
| MTOR | Kinase in mTORC1/2 complexes | Integrates PIP3 signaling with growth |
| PTENP1 | Pseudogene of PTEN | Regulates PTEN expression via competing endogenous RNA |
| SRC | Tyrosine kinase | Phosphorylates SHIP2, modulates activity |
| GRB2 | Adaptor protein | Recruits SHIP2 to activated receptors |
| SHC1 | Adaptor protein | Binds SHIP2 and regulates its function |
| PDPK1 | Kinase that phosphorylates AKT | Requires PIP3 for membrane recruitment |
| FOXO1 | Transcription factor inhibited by AKT | Readout of PIP3 signaling |
| GSK3B | Kinase inhibited by AKT | Downstream of PIP3 pathway |
How Is phosphatidylinositol trisphosphate phosphatase activity Regulated?
Phosphatidylinositol trisphosphate phosphatase activity is regulated at multiple levels. PTEN is controlled by phosphorylation, oxidation, and ubiquitination, which affect its membrane recruitment and catalytic activity. SHIP2 is regulated by anionic lipids such as phosphatidylserine, which enhance its 5-phosphatase activity. ER stress induces SKIP expression in skeletal muscle, linking cellular stress to insulin resistance. Additionally, voltage-sensing phosphatases like VSP are regulated by membrane potential, providing a rapid mechanism to modulate PIP3 levels in excitable cells. These regulatory mechanisms ensure tight control of PIP3 signaling in response to environmental cues.
phosphatidylinositol trisphosphate phosphatase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PTEN | Cancer, autism, Cowden syndrome | PTEN knockout or point-mutation cell lines |
| INPPL1 (SHIP2) | Type 2 diabetes, insulin resistance | SHIP2 knockout or overexpression in myotubes [4,8] |
| INPP5K (SKIP) | ER stress-induced insulin resistance | SKIP knockout in skeletal muscle cells |
| TPTE2 (VSP) | Neurological disorders | VSP overexpression in neurons |
| PIK3CA | Cancer | PIK3CA mutant knock-in models |
Cancer
Loss-of-function mutations in PTEN, a major phosphatidylinositol trisphosphate phosphatase, lead to PIP3 accumulation and constitutive AKT activation, driving tumorigenesis in various tissues. SHIP2 is also implicated in cancer, where its altered expression affects cell proliferation and survival. Targeting these phosphatases or their downstream effectors is a therapeutic strategy in cancers with PI3K pathway mutations.
Metabolic disorders
SKIP links endoplasmic reticulum stress to insulin resistance in skeletal muscle, and its overexpression impairs insulin signaling. SHIP2 regulates insulin sensitivity; its inhibition improves glucose uptake, making it a potential target for type 2 diabetes [4,8]. These findings highlight the role of PIP3 phosphatases in metabolic homeostasis.
Neurodevelopmental disorders
PTEN mutations are associated with autism spectrum disorders and macrocephaly, underscoring the importance of PIP3 regulation in brain development. VSP, a voltage-sensing phosphatase, may also contribute to neuronal excitability and signaling.
Adrenal lipoma
Recent studies show that adrenal lipoma formation occurs via PI(3,4,5)P3/AKT-dependent transdifferentiation of adrenocortical cells into adipocytes, implicating phosphatidylinositol trisphosphate phosphatase activity in this process.
From phosphatidylinositol trisphosphate phosphatase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of PTEN increase PIP3 and AKT signaling? | PTEN knockout cell line (e.g., HCT116) |
| How do point mutations in PTEN affect its phosphatase activity? | PTEN point-mutation knock-in via CRISPR |
| What is the effect of SHIP2 overexpression on insulin signaling? | SHIP2 overexpression in C2C12 myotubes |
| Can SKIP knockdown rescue ER stress-induced insulin resistance? | SKIP knockout in skeletal muscle cells |
| Does VSP voltage-sensing regulate PIP3 levels? | VSP knock-in with fluorescent tag in neurons |
| What is the role of PIP3 phosphatases in adrenal lipoma? | Adrenocortical cell knockout of PTEN |
How to Study the phosphatidylinositol trisphosphate phosphatase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Lipidomics (LC-MS) | PIP3 and PIP2 levels | Quantify changes in phosphatase activity |
| Immunoblotting | Phospho-AKT, total AKT | Assess downstream signaling |
| Live-cell imaging | PIP3 dynamics | Study spatial regulation |
| In vitro phosphatase assay | Enzyme kinetics | Screen inhibitors |
| CRISPR knockout | Gene function | Validate target dependency |
| RNA-seq | Transcriptional changes | Identify pathways affected |
| Proteomics | Protein interactions | Discover regulators |
| Phosphoproteomics | Signaling networks | Map AKT substrates |
Lipidomics and PIP3 measurement
Mass spectrometry-based lipidomics allows direct quantification of PIP3 and PIP2 levels in cells and tissues. This method is essential to confirm changes in phosphatidylinositol trisphosphate phosphatase activity [4,7].
Phosphoproteomics and AKT signaling
Phosphoproteomic profiling of AKT substrates (e.g., FOXO, GSK3) provides a readout of PIP3 signaling. Immunoblotting for phospho-AKT (Ser473) is a standard approach to assess phosphatase activity [2,6].
Live-cell imaging with PIP3 biosensors
Genetically encoded biosensors (e.g., GFP-AKT-PH) allow real-time visualization of PIP3 dynamics at the plasma membrane. This technique is useful to study spatial and temporal regulation of phosphatases.
In vitro phosphatase assays
Recombinant phosphatase domains can be incubated with PIP3 substrates, and released phosphate measured colorimetrically. This assay is used to determine kinetic parameters and inhibitor efficacy [4,8].
How CRISPR Can Be Used to Study GO:0034594 phosphatidylinositol trisphosphate phosphatase activity
Knockout
CRISPR knockout of PTEN, SHIP2, or SKIP is used to abolish phosphatidylinositol trisphosphate phosphatase activity and study consequent PIP3 accumulation and AKT activation. These models are valuable for cancer and metabolic research [2,6].
Point Mutation
Point mutations in the catalytic domain of PTEN (e.g., C124S) can be introduced via CRISPR to dissect the contribution of phosphatase activity versus other functions. Such models help understand disease-associated mutations.
Knock-in
Knock-in of fluorescent tags (e.g., GFP) into endogenous loci allows real-time tracking of phosphatase localization and dynamics. This approach is useful for studying VSP and SHIP2 in live cells [5,8].
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of phosphatases can be used to enhance PIP3 dephosphorylation and suppress AKT signaling. This is useful for testing therapeutic hypotheses [4,6].
How EDITGENE Supports phosphatidylinositol trisphosphate phosphatase activity Research
Researchers studying phosphatidylinositol trisphosphate phosphatase activity-related genes often need to determine whether a candidate gene is causally involved in PIP3 regulation, disease progression, or drug response. EDITGENE provides a comprehensive suite of CRISPR services to generate precisely engineered cell models that enable such investigations.
Contact EDITGENE today to design your custom CRISPR model for phosphatidylinositol trisphosphate phosphatase activity research.
Frequently Asked Questions About phosphatidylinositol trisphosphate phosphatase activity
What is phosphatidylinositol trisphosphate phosphatase activity?
It is the enzymatic activity that removes a phosphate from PIP3 to produce PIP2, as defined by GO:0034594.
What genes are involved in phosphatidylinositol trisphosphate phosphatase activity?
Key genes include PTEN, INPP5D (SHIP1), INPPL1 (SHIP2), INPP5K (SKIP), and TPTE2 (VSP) [1,2,4,5,6].
How does phosphatidylinositol trisphosphate phosphatase activity affect cancer?
Loss of this activity leads to PIP3 accumulation and AKT activation, promoting tumor growth; PTEN is a major tumor suppressor.
What diseases are associated with phosphatidylinositol trisphosphate phosphatase activity?
Cancer, autism, insulin resistance, type 2 diabetes, and adrenal lipoma [2,6,7].
What is the reaction catalyzed by phosphatidylinositol trisphosphate phosphatase?
Phosphatidylinositol trisphosphate + H2O = phosphatidylinositol bisphosphate + phosphate.
How is phosphatidylinositol trisphosphate phosphatase activity regulated?
It is regulated by phosphorylation, oxidation, anionic lipids, ER stress, and protein-protein interactions [2,4,6,8].
What are the substrates of phosphatidylinositol trisphosphate phosphatase?
The primary substrate is phosphatidylinositol 3,4,5-trisphosphate (PIP3), but some enzymes also act on PI(3,4)P2.
Which phosphatase removes the 5-phosphate from PIP3?
SHIP1 and SHIP2 are 5-phosphatases that convert PIP3 to PI(3,4)P2 [1,4].
How can I study phosphatidylinositol trisphosphate phosphatase activity in the lab?
Use lipidomics, phospho-AKT immunoblotting, live-cell imaging with PIP3 biosensors, and in vitro phosphatase assays [4,5,7].
What CRISPR models are available for phosphatidylinositol trisphosphate phosphatase research?
Knockout, point mutation, knock-in, and overexpression models can be generated for genes like PTEN and SHIP2 [2,6].
Conclusion
Phosphatidylinositol trisphosphate phosphatase activity (GO:0034594) is a fundamental enzymatic function that controls PIP3 levels and downstream AKT signaling. Its dysregulation is implicated in cancer, metabolic disorders, and neurodevelopmental conditions. Continued research using advanced CRISPR models and multi-omics approaches will further elucidate its mechanistic roles and therapeutic potential.
References
- 1. Krystal G et al.. 1999. SHIPs ahoy.. Int J Biochem Cell Biol 31(10):1007-10 PMID: 10582334
- 2. Rodríguez-Escudero I et al.. 2011. A comprehensive functional analysis of PTEN mutations: implications in tumor- and autism-related syndromes.. Hum Mol Genet 20(21):4132-42 PMID: 21828076
- 3. Zhang X et al.. 1998. Phosphatidylinositol signalling reactions.. Semin Cell Dev Biol 9(2):153-60 PMID: 9599410
- 4. Vandeput F et al.. 2006. The influence of anionic lipids on SHIP2 phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase activity.. Cell Signal 18(12):2193-9 PMID: 16824732
- 5. Kurokawa T et al.. 2012. 3' Phosphatase activity toward phosphatidylinositol 3,4-bisphosphate [PI(3,4)P2] by voltage-sensing phosphatase (VSP).. Proc Natl Acad Sci U S A 109(25):10089-94 PMID: 22645351
- 6. Ijuin T et al.. 2016. Phosphatidylinositol 3,4,5-Trisphosphate Phosphatase SKIP Links Endoplasmic Reticulum Stress in Skeletal Muscle to Insulin Resistance.. Mol Cell Biol 36(1):108-18 PMID: 26483413
- 7. Yanai S et al.. 2025. Adrenal lipoma formation via PI(3,4,5)P(3)/AKT-dependent transdifferentiation of adrenocortical cells into adipocytes.. Proc Natl Acad Sci U S A 122(37):e2510306122 PMID: 40924445
- 8. Thomas MP et al.. 2017. SHIP2: Structure, Function and Inhibition.. Chembiochem 18(3):233-247 PMID: 27907247
